CCG-100602
CCG-100602 inhibits RhoA/C-mediated, SRF-driven luciferase expression in PC-3 prostate cancer cells (IC50 :9.8 μM).
| Catalog Number | T22062 |
| Research Area | Cell Cycle/Checkpoint|||GPCR/G Protein|||MAPK |
| Molecular Formula | C21H17ClF6N2O2 |
| CAS# | 1207113-88-9 |
| Purity | 99.86% |
| SMILES | ClC1=CC=C(NC(C2CN(C(C3=CC(C(F)(F)F)=CC(C(F)(F)F)=C3)=O)CCC2)=O)C=C1 |
| Size | 25 mg |
| Supplier Page | https://www.targetmol.com/compound/CCG-100602 |
| Additional Information | https://www.targetmol.com/datasheet/T22062 |